Method of inducing immunity against stratum corneum chymotrytic enzyme
US7306927B2 · kind B2 · utility
0Cited by
4References
1Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 13, 2001 |
| Grant date | Dec 11, 2007 |
| Priority date | — |
| Expiry date | Jul 13, 2021 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/976
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosed nucleic acid primer sets, used in combination with quantitative amplification (PCR) of tissue cDNA, can indicate the presence of specific proteases in a tissue sample. The detected proteases are themselves specifically overexpressed in certain cancers, and their presence may serve for early detection of associated ovarian and other malignancies, and for the design of interactive therapies for cancer treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.